Zobrazeno 1 - 10
of 53
pro vyhledávání: '"Dijie Liu"'
Autor:
Spenser S. Johnson, Dijie Liu, Jordan T. Ewald, Claudia Robles-Planells, Casey Pulliam, Keegan A. Christensen, Khaliunaa Bayanbold, Brian R. Wels, Shane R. Solst, M. Sue O’Dorisio, Yusuf Menda, Douglas R. Spitz, Melissa A. Fath
Publikováno v:
Cancer Biology & Therapy, Vol 25, Iss 1 (2024)
Thioredoxin Reductase (TrxR) functions to recycle thioredoxin (Trx) during hydroperoxide metabolism mediated by peroxiredoxins and is currently being targeted using the FDA-approved anti-rheumatic drug, auranofin (AF), to selectively sensitize cancer
Externí odkaz:
https://doaj.org/article/c5a3742216384e1498585e82c931ad1b
Autor:
Xiang Sun, Chi Soo Kang, Inseok Sin, Shuyuan Zhang, Siyuan Ren, Haixing Wang, Dijie Liu, Michael R. Lewis, Hyun-Soon Chong
Publikováno v:
ACS Omega, Vol 5, Iss 44, Pp 28615-28620 (2020)
Externí odkaz:
https://doaj.org/article/5bfc85b08afd4e02bbd892d624b2b142
Autor:
Mengshi Li, Nicholas J. Baumhover, Dijie Liu, Brianna S. Cagle, Frédéric Boschetti, Guillaume Paulin, Dongyoul Lee, Zhiming Dai, Ephraim R. Obot, Brenna M. Marks, Ibrahim Okeil, Edwin A. Sagastume, Moustafa Gabr, F. Christopher Pigge, Frances L. Johnson, Michael K. Schultz
Publikováno v:
Pharmaceutics, Vol 15, Iss 2, p 414 (2023)
203Pb and 212Pb have emerged as promising theranostic isotopes for image-guided α-particle radionuclide therapy for cancers. Here, we report a cyclen-based Pb specific chelator (PSC) that is conjugated to tyr3-octreotide via a PEG2 linker (PSC-PEG-T
Externí odkaz:
https://doaj.org/article/eb3eea60c8ed4baa93aaaa7ffc84798d
Autor:
Kelly D. Orcutt, Kelly E. Henry, Christine Habjan, Keryn Palmer, Jack Heimann, Julie M. Cupido, Vijay Gottumukkala, Derek D. Cissell, Morgan C. Lyon, Amira I. Hussein, Dijie Liu, Mengshi Li, Frances L. Johnson, Michael K. Schultz
Publikováno v:
Molecules, Vol 27, Iss 18, p 5831 (2022)
[212Pb]VMT01 is a melanocortin 1 receptor (MC1R) targeted theranostic ligand in clinical development for alpha particle therapy for melanoma. 212Pb has an elementally matched gamma-emitting isotope 203Pb; thus, [203Pb]VMT01 can be used as an imaging
Externí odkaz:
https://doaj.org/article/1f754217da644730acfef98077e3421e
Autor:
Spenser S. Johnson, Dijie Liu, Jordan T. Ewald, Claudia Robles-Planells, Khaliunaa Bayanbold, Brian R. Wels, Shane R. Solst, M. Sue O’Dorisio, Bryan G. Allen, Yusuf Menda, Douglas R. Spitz, Melissa A. Fath
Publikováno v:
bioRxiv
Thioredoxin Reductase (TrxR) is a key enzyme in reactive oxygen species (ROS) detoxification and in redox regulation. Because cancer cells produce increased steady-state levels of ROS (i.e., superoxide and hydrogen peroxide), TrxR is viable target in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9db2b29a43eee17c37e62aa5bb71f97e
https://doi.org/10.1101/2023.05.07.539772
https://doi.org/10.1101/2023.05.07.539772
Publikováno v:
In Nuclear Medicine and Biology November-December 2023 126-127 Supplement
Autor:
Michael K. Schultz, Dijie Liu, Mengshi Li, Brianna S. Cagle, Zhiming Dai, Dongyoul Lee, Kelly Orcutt, Edwin Sagastume, Nicholas J. Baumhover, Ivy Vance, Amos Hedt, Yusuf Menda, Frances L. Johnson
Publikováno v:
Endocrine Abstracts.
Autor:
Kelly D, Orcutt, Kelly E, Henry, Christine, Habjan, Keryn, Palmer, Jack, Heimann, Julie M, Cupido, Vijay, Gottumukkala, Derek D, Cissell, Morgan C, Lyon, Amira I, Hussein, Dijie, Liu, Mengshi, Li, Frances L, Johnson, Michael K, Schultz
Publikováno v:
Molecules (Basel, Switzerland). 27(18)
[
Autor:
Michael King Schultz, Yusuf Menda, Dijie Liu, Mengshi Li, Frances Johnson, Brianna Cagle, Nicholas Baumhover, Ivy Vance
Publikováno v:
Cancer Research. 83:5049-5049
Objective: Pb-203 and Pb-212 have emerged as a promising elementally-matched theranostic pair for imaging-guided alpha-particle radiotherapy for cancer. A somatostatin receptor 2 (SSTR2)-targeted peptide coupled with novel Pb specific chelator (PSC)
Autor:
Melissa A. Fath, Dijie Liu, Claudia Robles-Planells, Jordan T. Ewald, Keegan A. Christensen, Spenser S. Johnson, Stephen A. Graves, Douglas R. Spitz, Yusuf Menda, M. Sue O’Dorisio
Publikováno v:
Cancer Research. 83:5034-5034
Introduction/Background: Atypical lung carcinoids and lung neuroendocrine carcinomas (NECs) are currently incurable. Most of these cancers express the C-X-C chemokine receptor 4 (CXCR4), making CXCR4 an attractive target for cancer diagnosis and trea